MedPath

Magnetically Navigated vs. Manually Guided Radiofrequency in Atrioventricular-node-reentry-tachycardia

Phase 4
Completed
Conditions
Atrioventricular Nodal Reentry Tachycardia
Radiofrequency Ablation
Interventions
Procedure: RF-ablation
Registration Number
NCT00875914
Lead Sponsor
Deutsches Herzzentrum Muenchen
Brief Summary

The MAGMA-AVNRT study compares two different methods of handling the ablation catheters for av-node-reentry-tachycardia with regard to x-ray dose, safety and success: manually guided vs magnetically navigated RF-catheter.

Detailed Description

AV-node reentry tachycardia can be treated by radiofrequency ablation or modulation of the slow pathway of the av node. The success rate is 90 to 95%.

There are different options to navigate the ablation catheter: manually guided vs magnetically guided.

For magnetic guidance two magnets are positioned beneath the patient. A mangetic field is induced and a catheter with a ferromagnetic tip can be navigated from outside with a joystick by modifying the vectors of the magnetic field.

We hypothesized that a magnetic guidance of the RF-ablation catheter results in lower x-ray time and dose for the patient and the physician with comparable safety und success rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • 18 to 70 years old
  • suspected AV-node-reentry-tachycardia
  • written informed consent
Exclusion Criteria
  • pregnancy
  • contraindication against electrophysiological study or ablation
  • congenital heart disease or other anatomical abnormalities
  • previous surgical procedure involving atrium except aorto-coronary bypass grafts
  • psychiatric disease that makes a completion of study improbable
  • severe comorbidities with a life expectancy less than 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Manually guidedRF-ablationTreatment with manually guided RF-catheter
Magnetically navigatedRF-ablationTreatment with magnetically navigated RF-catheter.
Primary Outcome Measures
NameTimeMethod
Total x-ray time and dose for patientelectrophysiological examination
Secondary Outcome Measures
NameTimeMethod
short-term and long-term-successend of procedure and 6 months after procedure
Duration of electrophysiological study (ablation included)procedure
number of RF-applicationprocedure
Safety of ablation (AV-Block, perforation)end of electrophysiological study
X-ray time and dose for physicianelectrophysiological study

Trial Locations

Locations (1)

University Hospital Bergen

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath